Kheradmand Ehsan, Pourhossein Meraj, Amini Gilda, Saadatnia Mohammad
Isfahan Neurosciences Research Center, Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Genetics, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2014 Feb 28;3:80. doi: 10.4103/2277-9175.127993. eCollection 2014.
Different risk factors have been suggested for ischemic stroke in young adults. In a group of these patients despite of extensive diagnostic work-up, the primary cause remains unknown. Coagulation tendency is accounted as a possible cause in these patients. Previous studies on factor V Leiden (FVL) as the main cause of inherited thrombophilia for clarifying the role of FVL in stroke have resulted in controversial findings. The current study investigates the role of this factor in ischemic stroke among Iranians.
This case-control study was performed between September 2007 and December 2008 in Isfahan, Iran. The case group comprised of 22 patients of which 15 were males and 7 were females with age range of ≤50 years, diagnosed as ischemic stroke without classic risk factors and the control group consisted of 54 healthy young adults. After filling consent form, venous blood samples were obtained and sent to the laboratory for genetic examination.
No FVL mutation was found in the case group. There was one carrier of the mutation as heterozygous in the control group (relative frequency = 1.85%).
Based on our study, FVL might not be considered as an independent risk factor for ischemic stroke in Iranian individuals who are not suffering from other risk factors of ischemic stroke.
针对年轻成年人缺血性卒中,已提出了不同的危险因素。在这组患者中,尽管进行了广泛的诊断检查,但其主要病因仍不明。凝血倾向被认为是这些患者可能的病因。先前关于作为遗传性血栓形成主要原因的凝血因子V莱顿(FVL),以阐明FVL在卒中中的作用的研究,结果存在争议。本研究调查该因素在伊朗人缺血性卒中中的作用。
本病例对照研究于2007年9月至2008年12月在伊朗伊斯法罕进行。病例组由22例患者组成,其中15例为男性,7例为女性,年龄≤50岁,被诊断为无经典危险因素的缺血性卒中,对照组由54名健康年轻人组成。在填写同意书后,采集静脉血样本并送至实验室进行基因检测。
病例组未发现FVL突变。对照组中有1名杂合子突变携带者(相对频率 = 1.85%)。
基于我们的研究,对于未患有缺血性卒中其他危险因素的伊朗个体,FVL可能不被视为缺血性卒中的独立危险因素。